Your browser doesn't support javascript.
loading
Whole-Body and Forearm Muscle Protein Metabolism in Patients With Acromegaly Before and After Treatment.
Arlien-Søborg, Mai C; Dal, Jakob; Madsen, Michael Alle; Høgild, Morten Lyng; Pedersen, Steen B; Jessen, Niels; Jørgensen, Jens O L; Møller, Niels.
Afiliación
  • Arlien-Søborg MC; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
  • Dal J; Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
  • Madsen MA; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
  • Høgild ML; Department of Endocrinology, Aalborg University Hospital, Aalborg 9000, Denmark.
  • Pedersen SB; Steno Diabetes Centre North, Aalborg University Hospital, Aalborg 9000, Denmark.
  • Jessen N; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
  • Jørgensen JOL; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
  • Møller N; Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus 8200, Denmark.
J Clin Endocrinol Metab ; 108(9): e671-e678, 2023 08 18.
Article en En | MEDLINE | ID: mdl-37036819
ABSTRACT

BACKGROUND:

Active acromegaly is characterized by increased lean body mass, but the mechanisms underlying the protein anabolic effect are unclear.

AIM:

To study if active acromegaly induces reversible changes in whole-body and skeletal muscle protein kinetics. PATIENTS AND

METHODS:

Eighteen patients with acromegaly were investigated before and 47 ± 10 weeks after disease control by surgery (n = 8) and/or medical treatment (n = 10). Labeled phenylalanine and tyrosine tracers were employed to assess whole-body and regional forearm muscle protein kinetics. Intramyocellular protein signaling was assessed in skeletal muscle biopsies, and whole-body dual-energy X-ray absorptiometry scan and indirect calorimetry assessed lean body mass (LBM) and resting energy expenditure, respectively.

RESULTS:

Disease control induced a 7% decrease in lean body mass (P < .000) and a 14% decrease in LBM-adjusted energy expenditure. Whole-body phenylalanine breakdown decreased after disease control (P = .005) accompanied by a decrease in the degradation of phenylalanine to tyrosine (P = .005) and a decrease in whole-body phenylalanine synthesis (P = .030). Skeletal muscle protein synthesis tended to decrease after disease control (P = .122), whereas the muscle protein breakdown (P = .437) and muscle protein loss were unaltered (P = .371). Unc-51 like autophagy activating kinase 1 phosphorylation, an activator of protein breakdown, increased after disease control (P = .042).

CONCLUSIONS:

Active acromegaly represents a reversible high flux state in which both whole-body protein breakdown and synthesis are increased, whereas forearm muscle protein kinetics are unaltered. Future studies are needed to decipher the link between protein kinetics and the structure and function of the associated growth hormone-induced increase in lean body mass.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Acromegalia Límite: Humans Idioma: En Revista: J Clin Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Asunto principal: Acromegalia Límite: Humans Idioma: En Revista: J Clin Endocrinol Metab Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca